Sun Pharmaceutical Industries Ltd.

Financial

	Sun Pharma Inds.	Torrent Pharma	Cipla
Operational Metrics
Pharmaceutical Sector
Number of ANDA's Filed in USA	661.0 .	172.0 .	282.0 .
Number of ANDA's Approved By USFDA	542.0 .	132.0 .	217.0 .
Domestic Sales Growth - YoY	12.0 %	12.3 %	6.8 %
US DMF Filings	529.0 .	n/a	2472.0 .
US DMF Approval	401.0 .	n/a	n/a
R&D as a % of Total Sales	6.5 %	5.0 %	6.2 %
Financials
5 yr Average ROE	11.67 %	20.79 %	13.9 %
5yr average Equity Multiplier	1.33	2.16	1.25
5yr Average Asset Turnover Ratio	0.57	0.69	0.78
5yr Avg Net Profit Margin	15.4 %	13.95 %	14.31 %
Price to Book	5.27	15.93	3.85
P/E	36.7	60.39	22.25
5yr Avg Cash Conversion Cycle	-46.88 Days	-186.79 Days	-4.31 Days
Inventory Days	65.22 Days	54.98 Days	57.83 Days
Days Receivable	84.33 Days	40.18 Days	50.64 Days
Days Payable	175.41 Days	298.32 Days	105.99 Days
5yr Average Interest Coverage Ratio	44.12	7.38	53.73
5yr Avg ROCE	18.0 %	25.78 %	19.36 %
5yr Avg Operating Profit Margin	26.44 %	30.49 %	23.02 %
5 yr average Debt to Equity	0.06	0.66	0.03
5yr CAGR Net Profit	30.35 %	8.83 %	17.0 %
5yr Average Return on Assets	8.92 %	9.73 %	11.19 %
Shareholdings
Promoter Holding	54.48 %	68.31 %	29.19 %
Share Pledged by Promoters	0.88 %	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	-2.94 %	-4.42 %
Change in Mutual Fund Holding (3 Yrs)	0.79 %	-2.83 %	7.05 %

Business

	Sun Pharma Inds.	Torrent Pharma	Cipla
Product Wise Break-Up	Product Wise Break-Up India Branded Generics 32.0 US Formulations 30.0 Emerging Market 17.0 Western Europe & Other Markets 16.0 Active Pharmaceutical Ingredient (API) 5.0 Domestic formulations 0 Contract Manf. 0 Brazil/Latam 0 Germany/Europe 0 New ventures 0 Pharmaceuticals 0	Product Wise Break-Up Active Pharmaceutical Ingredient (API) 0 Western Europe & Other Markets 0 Contract Manufacturing 6.15 Emerging Market 0 New ventures 0 Domestic Formulations 42.15 Germany 13.15 Brazil 8.98 US Formulations 20.71 Pharmaceuticals 0 India Branded Generics 0 Others 8.86	Product Wise Break-Up Active Pharmaceutical Ingredient (API) 0 Western Europe & Other Markets 0 Contract Manf. 0 Emerging Market 0 New ventures 6.32 Domestic formulations 0 Germany/Europe 0 Brazil/Latam 0 US Formulations 0 Pharmaceutical 93.68 India Branded Generics 0
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Central Nervous System (CNS) 20.0 Cardiac Science 17.0 Gastro Intestinal 14.0 Anti - Diabetes 8.0 Pain Management 7.0 Anti-Infective 6.0 Respiratory Systems 5.0 Vitamins / Minerals / Nutrients 5.0 Gynecology 4.0 Dermatology 4.0 Ophthalmology 3.0 Urology 3.0 Anti-infectives 0 Cardiac 0 Gastro Intestinal 0 Antivirals 0 Derma 0 Neuro /CNS 0 Gynaec. 0 Vitamins 0 Antineoplast 0 Opthal/Otologicals 0 Oncology 0 Anti Diabetic 0 Others 4.0	-	Therapeutic Area Wise Break-Up - Domestic Anti - Diabetes 5.5 Gynecology 0 Cardiac Science 0 Antivirals 0 Urology 5.1 Anti-Infective 0 Pain Management 0 Central Nervous System (CNS) 4.5 Respiratory Systems 0 Anti - Diabetes 0 Vitamins / Minerals / Nutrients 0 Gastro Intestinal 5.5 Ophthalmology 2.6 Central Nervous System (CNS) 0 Ophthalmology 0 Derma 3.5 Dermatology 0 Anti-Infective 13.8 Antineoplast 0 Gynaec. 0 Oncology 0 Cardiac Science 11.8 Vitamins 0 Others 47.7
Location Wise Break-Up	Location Wise Break-Up India 33.39 USA 32.68 Emerging Market 19.13 Rest of the World 14.8 Germany 0 Brazil 0 SAGA 0 Europe 0 Global API 0 North America 0	Location Wise Break-Up Europe 0 SAGA 0 Emerging Market 0 India 56.99 USA 9.69 Germany 9.69 North America 0 Rest of the World 0 Global API 0 Brazil 6.86 Others 16.77	Location Wise Break-Up Europe 12.0 SAGA 13.0 Emerging Market 0 India 44.0 USA 0 Germany 0 North America 28.0 Rest of the World 0 Global API 1.0 Brazil 0 Others 2.0

Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries Ltd.

SIGN UP FOR FREE